Deneufbourg, J.-M., Bouillenne, C., MAGGIPINTO, G., & Lupo, A. (26 July 1992). Lymphocytes subsets before and after neoadjuvant polychemotherapy for head and neck cancers [Poster presentation]. 3rd International Conference on Head and Neck Cancer, San Francisco, United States - California. Peer reviewed |
Deneufbourg, J.-M., Bouillenne, C., MAGGIPINTO, G., & Lupo Aurélia. (November 1991). Changes of lymphocytes subsets after neoadjuvant chemotherapy for head and neck cancers. European Journal of Cancer and Clinical Oncology, 27 (suppl.3), 16. doi:10.1016/0277-5379(91)91160-k Peer Reviewed verified by ORBi |
Deneufbourg, J.-M., Lupo, A., Bouillenne, C., Reuter, A., Ghysen, P., Lopez, M., & Franchimont, P. (November 1987). Immunological modifications associated with radiotherapy of larynx cancer : longitudinal analysis and correlations with the course of disease [Poster presentation]. 4th European Conference on Clinical Oncology and Cancer Nursing, Madrid, Spain. Peer reviewed |
Deneufbourg, J.-M., & Bouillenne, C. (1982). Positive correlation between HLA-B35 and breast cancer incidence. In 13th UICC Cancer Congress Proceedings (pp. 523). Genève, Switzerland: Union Internationale contre le cancer UICC. Peer reviewed |
Deneufbourg, J.-M., & Bouillenne, C. (07 June 1982). Corrélation positive entre HLA-B35 et l'incidence du cancer du sein [Poster presentation]. 2 ème Forum de Cancérologie PARIS, Paris, France. Peer reviewed |
Deneufbourg, J.-M., & Bouillenne, C. (1980). Corrélation entre les groupes HLA et le cancer du larynx. Incidence et pronostic à 5 ans. Bulletin du Cancer, 67 (5), 531-534. Peer Reviewed verified by ORBi |
Deneufbourg, J.-M., & Bouillenne, C. (1976). HLA and larynx cancer. In J. S. A. Dausset (Ed.), HLA and Disease (pp. 222). Paris, France: Editions INSERM. Peer reviewed |
Bouillenne, C., & Deneufbourg, J.-M. (1976). HLA and Breast Cancer. In J. S. A. Dausset (Ed.), H L A and Disease (pp. 219). Paris, France: Editions INSERM. Peer reviewed |